Jonathan David Schwartz Rocket Pharmaceuticals, Inc. (RCKT) insider trading activity

Jonathan David Schwartz is of ROCKET PHARMACEUTICALS, INC.. Currently has a direct ownership of 301,609 shares of RCKT, which is worth approximately $971,180. The most recent transaction as insider was on Sep 08, 2025, when has been sold 80,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 302K

28.21% 3M change

80.66% 12M change

Total Value Held $971,180

Jonathan David Schwartz Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 08 2025	BUY Grant, award, or other acquisition	-	80,000 Added 20.96%	301,609 Common Stock
Aug 19 2025	SELL Open market or private sale	$2,415 $3.0 p/Share	805 Reduced 0.36%	221,609 Common Stock
Aug 18 2025	SELL Open market or private sale	$5,140 $3.06 p/Share	1,680 Reduced 0.75%	222,414 Common Stock
Aug 14 2025	SELL Open market or private sale	$33,706 $3.02 p/Share	11,161 Reduced 4.74%	224,094 Common Stock
May 20 2025	SELL Open market or private sale	$5,166 $6.45 p/Share	801 Reduced 0.34%	235,255 Common Stock
May 16 2025	SELL Open market or private sale	$10,330 $6.53 p/Share	1,582 Reduced 0.67%	236,056 Common Stock
Feb 25 2025	SELL Open market or private sale	$69,108 $10.58 p/Share	6,532 Reduced 2.68%	237,638 Common Stock
Feb 11 2025	BUY Grant, award, or other acquisition	-	80,318 Added 24.12%	252,731 Common Stock
Nov 21 2024	SELL Open market or private sale	$40,415 $13.05 p/Share	3,097 Reduced 1.86%	163,852 Common Stock
Aug 16 2024	SELL Open market or private sale	$50,135 $18.5 p/Share	2,710 Reduced 1.6%	166,949 Common Stock
May 17 2024	SELL Open market or private sale	$64,305 $23.35 p/Share	2,754 Reduced 1.6%	169,659 Common Stock
Feb 17 2023	SELL Open market or private sale	$67,796 $19.06 p/Share	3,557 Reduced 3.63%	94,546 Common Stock
Mar 30 2022	SELL Open market or private sale	$731,250 $16.25 p/Share	45,000 Reduced 20.04%	179,529 Common Stock
Feb 01 2021	BUY Exercise of conversion of derivative security	$325,567 $1.45 p/Share	224,529 Added 50.0%	224,529 Common Stock

Also insider at

TRHC

Tabula Rasa HealthCare, Inc. Healthcare

JDS